Class III CE 0373 intradermal injectable medical devices
Formula with European Patent No. 21202527.4
Skin-F ® 22
In 1-mL syringe, contains 22 mg/ml cross-linked sodium hyaluronate in sterile buffered water with added glycine and proline.
Skin-F ® 24
In 1-mL syringe, contains 24 mg/ml cross-linked sodium hyaluronate, in sterile buffered water, with added glycine and proline.
Skin-F ® 26
In 1-mL syringe, contains 26 mg/ml cross-linked sodium hyaluronate, in sterile buffered water, with added glycine and proline.
Skin-F ® MAN 22
In 1-mL syringe, contains 22 mg/ml cross-linked sodium hyaluronate in sterile buffered water with added glycine and proline.
Skin-F ® MAN 24
In 1-mL syringe, contains 24 mg/ml cross-linked sodium hyaluronate, in sterile buffered water, with added glycine and proline.
Skin-F ® MAN 26
In 1-mL syringe, contains 26 mg/ml cross-linked sodium hyaluronate, in sterile buffered water, with added glycine and proline.
Fillervit ® F 22
In 1-mL syringe, contains 22 mg/ml cross-linked sodium hyaluronate in sterile buffered water with added glycine and proline.
Fillervit ® F 24
In 1-mL syringe, contains 24 mg/ml cross-linked sodium hyaluronate, in sterile buffered water, with added glycine and proline.
Fillervit ® F 26
In 1-mL syringe, contains 26 mg/ml cross-linked sodium hyaluronate, in sterile buffered water, with added glycine and proline.
SKIN-F Total Lift
In 10 ml syringe, contains 20 mg/ml cross-linked sodium hyaluronate, in sterile buffered water, with glycine and proline added.
IOFILL 1-2-3
Innovative filler based on medium-high molecular weight cross-linked hyaluronic acid obtained by bacterial fermentation, glycine and proline. Monophasic hydrogel for correction of soft tissue deficits.
THIS PAGE IS INTENDED SOLELY FOR HEALTH CARE PROFESSIONALS
By clicking "CONFIRM", you declare under your own responsibility that you are a physician or other health professional.